PT-141 Providers in Wisconsin
1 provider offering PT-141 in Wisconsin
About PT-141
PT-141 (Bremelanotide, brand name Vyleesi) is a melanocortin receptor agonist FDA-approved for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. Unlike other sexual dysfunction treatments that act on the vascular system, PT-141 works through the central nervous system, specifically the melanocortin receptors in the brain that regulate sexual arousal and desire.
Learn more about PT-141Milwaukee-area anti-aging practice offering thymosin alpha-1/beta-4, BPC-157, GHK-Cu, epitalon, CJC/ipamorelin, PT-141, semax, and selank peptide protocols.
View ProfileMedical Disclaimer: This content is for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare provider before beginning any peptide therapy treatment.